The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway

被引:49
|
作者
Boileau, C
Pelletier, JP
Tardif, G
Fahmi, H
Laufer, S
Lavigne, M
Martel-Pelletier, J
机构
[1] Univ Montreal, Notre Dame Hosp, Ctr Hosp, Osteoarthrit Res Unit, Montreal, PQ H2L 4M1, Canada
[2] Univ Tubingen, Tubingen, Germany
[3] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada
关键词
D O I
10.1136/ard.2004.026906
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: MMP-13 is one of the most important metalloproteases (MMP) involved in osteoarthritis. Licofelone, a novel dual inhibitor of cyclo-oxygenases ( COX) and 5-lipoxygenase (5-LOX), can modulate MMP-13 production in human osteoarthritis chondrocytes. Objective: To evaluate the impact of licofelone on MMP-13 expression/production, promoter, and major MAP kinase signalling pathways and transcription factors. Methods: Human osteoarthritis chondrocytes were stimulated by interleukin 1 beta ( IL1 beta) and treated with or without: licofelone (0.3, 1, or 3 mg/ml); NS-398 ( 10 mu M; a specific COX-2 inhibitor); or BayX-1005 ( 10 mM; a specific 5-LOX inhibitor). MMP-13 synthesis was determined by specific enzyme linked immunosorbent assay, and expression by real time polymerase chain reaction. The effect of licofelone on the MMP-13 promoter was studied through transient transfection; dexamethasone ( 1027 M) was used as comparison. The effect on IL1 beta induced MMP-13 signalling pathways was determined using specific ELISA for phosphorylated MAP kinases and transcription factors. Results: Licofelone dose dependently inhibited the IL1 beta stimulated production and expression of MMP-13. NS-398 and BayX-1005 had very little effect. Licofelone also inhibited MMP-13 transcription on each of the promoter constructs used. The licofelone inhibition was comparable to that obtained with dexamethasone. Licofelone had no effect on phosphorylated p44/42 or JNK1/2; however, it decreased phosphorylated c-jun and inhibited phosphorylated p38, CREB, and AP-1 activity. Conclusions: Licofelone inhibited MMP-13 production under proinflammatory conditions on human osteoarthritis chondrocytes, through inhibition of the p38/AP-1 pathway and the transcription factor CREB. This may explain some of the mechanisms whereby licofelone exerts its positive effect on osteoarthritic changes.
引用
收藏
页码:891 / 898
页数:8
相关论文
共 11 条
  • [1] The regulation of human MMP-13 by licofelone, an inhibitor of cyclooxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signaling pathway
    Boileau, C
    Pelletier, JP
    Mineau, F
    Tardif, G
    Fahmi, H
    Laufer, S
    Lavigne, M
    Martel-Pelletier, J
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S287 - S287
  • [2] Inhibtion of human MMP-13 expression by licofelone, a dual inhibitor of cyclooxygenases/5-lipoxygenase in human osteoarthritic chondrocytes
    Boileau, C
    Pelletier, JP
    Laufer, S
    Ranger, P
    Martel-Pelletier, J
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 262 - 263
  • [3] Inhibition of human MMP-13 expression by licofelone, a dual inhibitor of cyclooxygenase/5-lipoxygenase in human osteoarthritic (OA) chondrocytes.
    Boileau, C
    Pelletier, JP
    Laufer, S
    Ranger, P
    Martel-Pelletier, J
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S283 - S283
  • [4] The regulation of human metalloprotease-13 by licofelone, an inhibitor of cyclooxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 mitogen-activated protein kinase signaling pathway
    Boileau, C
    Pelletier, JP
    Mineau, F
    Tardif, G
    Fahmi, H
    Laufer, S
    Lavigne, M
    Martel-Pelletier, J
    OSTEOARTHRITIS AND CARTILAGE, 2004, 12 : S100 - S100
  • [5] Differential regulation of cytokine-induced MMP-1 and MMP-13 expression by p38 kinase inhibitors in human chondrosarcoma cells: potential role of Runx2 in mediating p38 effects
    Pei, Yong
    Harvey, Anita
    Yu, Xiao-Peng
    Chandrasekhar, Srinivasan
    Thirunavukkarasu, Kannan
    OSTEOARTHRITIS AND CARTILAGE, 2006, 14 (08) : 749 - 758
  • [6] Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase
    Ravanti, L
    Heino, J
    López-Otín, C
    Kähäri, VM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (04) : 2446 - 2455
  • [7] Novel p38 MAP kinase inhibitor R-130823 suppresses IL-6, IL-8 and MMP-13 production in spheroid culture of human synovial sarcoma cell line SW 982
    Wada, Y
    Shimada, K
    Kimura, T
    Ushiyama, S
    IMMUNOLOGY LETTERS, 2005, 101 (01) : 50 - 59
  • [8] Nuclear factor (NF)-κB and p38 mitogen-activated protein (MAP) kinase inhibition augment apoptosis induced by a selective cyclo-oxygenase 2 inhibitor in human lung cancer
    Alam, M
    Wang, JH
    Qadri, SS
    Coffey, JC
    O'Donnell, AF
    Aherne, T
    Redmond, HP
    BRITISH JOURNAL OF SURGERY, 2004, 91 (09) : 1223 - 1223
  • [9] Possible role for hepatocyte growth factor-induced collagenase-3 production in human osteoarthritic cartilage: Involvement of both SAP/JNK pathway and a sensitive p38 MAP kinase inhibitor cascade.
    Reboul, P
    Pelletier, JP
    Tardif, G
    Benderdour, M
    Ranger, P
    Martel-Pelletier, J
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S166 - S166
  • [10] Signaling pathway for TNF-α-induced MMP-9 expression: Mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells
    Lee, Se-Jung
    Park, Sung-Soo
    Lee, Ung-Soo
    Kim, Wun-Jae
    Moon, Sung-Kwon
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2008, 8 (13-14) : 1821 - 1826